Latest CRH Medical Corp (CRMMF) Headlines /C
Post# of 14
/C O R R E C T I O N from Source -- CRH Medical Corporation/
CNW Group - Fri Jan 10, 9:14AM CST
In c7873 disseminated today at 07:00e, please note that the US$ amount at the end of the 1st paragraph should read "US$7,680,000" not "US$7,860,000". Corrected copy follows:
CRH Medical announces anticipated revenue for the year ending December 31, 2013
CNW Group - Fri Jan 10, 6:00AM CST
CRH Medical Corporation (TSX: CRH, OTCQX: CRMMF), a North American medical company focused on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that it expects to report revenue for the year ended December 31, 2013 of approximately US$7,860,000.
Early Warning Report Issued Pursuant to National Instrument 62-103 in Respect of the Acquisition of Common Shares in the Capital of CRH Medical Corporation
Marketwire - Tue Jan 07, 3:01PM CST
Fernbank LLC ("Fernbank") announces that following a set of transactions ending on January 6, 2014 which were conducted through the facilities of the Toronto Stock Exchange, it acquired 108,900 common shares (the "Acquisition") of CRH Medical Corporation ("CRH" or the "Corporation"). Immediately following the Acquisition, Fernbank owned, controlled and had direction over an aggregate of 4,905,900 common shares of the Corporation on a non-diluted basis, representing approximately 10.1% of CRH's outstanding common shares at that time.
CRH Medical Corporation adopts advance notice policy
CNW Group - Fri Dec 13, 1:00PM CST
CRH Medical Corporation (the "Corporation") (TSX: CRH) (OTCQX: CRMMF), today announced that its board of directors has adopted an advance notice policy regarding the nomination of directors (the "Advance Notice Policy") effective December 12, 2013. The purpose of the Advance Notice Policy is to provide shareholders, directors and management of the Corporation with direction on the procedure for shareholder nomination of directors. The Advance Notice Policy is the framework by which the Corporation seeks to fix a deadline by which registered or beneficial holders of common shares of the Corporation must submit director nominations to the Corporation prior to any annual or special meeting of shareholders and sets forth the information that a shareholder must include in the notice to the Corporation for the notice to be in proper written form. No person will be eligible for election as a director of the Corporation unless nominated in accordance with the provisions of the Advance Notice Policy.
CRH Medical Announces Third Quarter Results
CNW Group - Mon Oct 28, 4:00PM CDT
Year-To-Date Revenue Increases 10% Compared to Same Period Last Year
CRH Medical Announces Second Quarter Results
CNW Group - Mon Jul 22, 4:00PM CDT
Revenue Increases 16% Compared to Same Period Last Year
CRH Medical Announces Re-Election of Directors and Auditor
CNW Group - Thu Jun 20, 5:28PM CDT
CRH Medical Corporation (the "Company") (TSX: CRH) (OTCQX: CRMMF), announces that the nominees listed in the management proxy circular for the 2013 Annual Meeting of Shareholders were re-elected as directors.
CRH Medical To Present at Bloom Burton & Co. Healthcare Investor Conference
CNW Group - Thu May 09, 12:30PM CDT
CRH Medical Corporation (TSX: CRH) (OTCQX: CRMMF), a North American medical company focussed on providing physicians with innovative products for the treatment of gastrointestinal diseases, today announced that Edward Wright, the Company's Chief Executive Officer, will present at the second annual Bloom Burton & Co. Healthcare Investor Conference on Wednesday, May 22, at 3:00 pm Eastern Time. The conference will be held at the Toronto Board of Trade in Toronto, Ontario.
CRH Medical Announces First Quarter Results
CNW Group - Tue Apr 23, 3:00PM CDT
-First Quarter Revenue Increases 9% Compared to Same Period Last Year -
CRH Medical Announces Fiscal 2012 Results
CNW Group - Wed Mar 20, 4:00PM CDT
- Also Announces Date for First Quarter, 2013 Results-